Anika Gupta Vatsa is a principal at GV focusing on biotech investments. She represents GV on boards and previously worked at Foundation Medicine and Merck.
At firms with a similar stage, sector and check size.
One email when Anika's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckAnika Gupta Vatsa is a principal at GV focusing on biotech investments. She represents GV on boards and previously worked at Foundation Medicine and Merck.
Anika Gupta invests through GV, which writes checks of $10M to $30M+ at seed, series a, series b.
A warm intro from a founder GV backed works best.
Foundation Medicine; Merck; bioinformatics frameworks for patient stratification at Foundation Medicine; immunotherapy response prediction at Merck.
Last updated 2026-10-15. Is this you? Ask for a correction.